04312nam 2201285z- 450 991040408440332120231214133259.03-03928-759-1(CKB)4100000011302294(oapen)https://directory.doabooks.org/handle/20.500.12854/61309(EXLCZ)99410000001130229420202102d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierTreatment Strategies and Survival Outcomes in Breast CancerMDPI - Multidisciplinary Digital Publishing Institute20201 electronic resource (264 p.)3-03928-758-3 Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and targeted therapy). Advances in technologies such as oncoplastic surgery, radiation planning and delivery, and genomics, and the development of novel systemic therapy agents alongside their evaluation in ongoing clinical trials continue to strive for improvements in outcomes. In this Special Issue, we publish a collection of studies looking at all forms of therapeutic strategies for early and advanced breast cancer, focusing on their outcomes, notably survival.relative survivalyoung womencancer treatmentfulvestrantlapatinibtumor biologyantihormone therapymastectomyaromatase inhibitorschemotherapyserum biomarkercyclin Eanthracycline resistancezero-inflated Poisson regression modellymph-node ratioCHEK2comparative effectivenessbreast-conserving therapytaxane sensitivityliquid biopsyHER2 c-erbB2colorectal cancerinfiltrating breast cancersurvivalexercise characteristicslactate dehydrogenasebiomarkerbreast cancer survivorsBRCAdisease-free survivalPIK3CAmetastatic breast cancercell-free DNAinvasive breast cancerradiotherapyMetforminsocial well-beinggene expressioncontralateral breast cancerbasal-like breast cancerLMK-235Src kinaseHER2/neuLKB1Older womenLDHmutation carriersstage IVmammography screeningNCDBcMetSEERpertuzumabphysical functionoutcomeribociclibolder patientsgeriatric oncologymetastaticoverdiagnosisnext-generation sequencingabemaciclibEndocrine therapymonitoring metastatic breast cancerbreast cancercirculating tumor cellsBreast CancerPALB2histone deacetylaseprognosisphysical activitytrastuzumabductal carcinoma in situcontralateral prophylactic mastectomyERCC1family historyT-DM1ATMadvanced breast cancerincidencepalbociclibHDAC5 inhibitorsAPOBEC3BCheung Kwok-Leungauth1325396BOOK9910404084403321Treatment Strategies and Survival Outcomes in Breast Cancer3036843UNINA